MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Why is HAL effective in improving gait and balance function in Parkinson’s disease?

    N. Togashi, K. Tateno, Y. Kondo, M. Masanobu, A. Kawanami, K. Hasegawa (Sagamihara, Japan)

    Objective: We performed rehabilitation using a Hybrid Assisted Limb (HAL) for PD and found that gait and balance functions improved before and after HAL rehabilitation.…
  • 2023 International Congress

    Gray matter volume changes in occipital and temporal visual brain region are associated with freezing of gait in Parkinson’s

    YX. Li, ZL. Luo, XL. Yang (Kunming, China)

    Objective: This study aimed to investigate the association of changed gray matter volume(GMV)with Freezing of gait(FOG) in Parkinson’s disease(PD). Background: FOG is a characteristic gait…
  • 2023 International Congress

    Predicting ALS progression using remote sensor-based assessments

    D. Anderson, A. Keil, D. Amato, M. Merickel, M. Kantartjis, S. Jezewski, S. Johnson, S. Polyak, B. Severson, J. Severson (Horsham, USA)

    Objective: To develop a predictive model of amyotrophic lateral sclerosis (ALS) progression using self-administered digital assessments. Background: Remote fit-for-purpose sensor-based assessments stand to enhance the…
  • 2023 International Congress

    Jumping to Conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

    IP. Pachi, VP. Papadopoulos, CK. Koros, AMS. Simitsi, AB. Bougea, MB. Bozi, NP. Papagiannakis, RFP. Soldatos, DK. Kolovou, GP. Pantes, NS. Scarmeas, LAX. Xenaki, GP. Paraskevas, KV. Voumvourakis, SGP. Papageorgiou, KK. Kollias, NS. Stefanis, LS. Stefanis (Athens, Greece)

    Objective: The aim was to explore the correlations between Jumping to Conclusions (JtC) tendency and neuropsychiatric features in patients with early Parkinson’s disease (PD). Background:…
  • 2023 International Congress

    Placebo response in Parkinson’s disease (PD) is predicted by expression levels of a specific brain network

    J. Barbero, C. Tang, A. Vo, Y. Ma, S. Peng, B. Brakedal, C. Dölle, N. Brekke, C. Tzoulis, D. Eidelberg (Manhasset, USA)

    Objective: To determine whether baseline expression levels for the previously validated sham surgery-related metabolic pattern (SSRP) can be used to predict the magnitude of the…
  • 2023 International Congress

    Neuropsychological and quality of life outcome comparison after awake and asleep pallidal deep brain stimulation (DBS) surgery for Parkinson’s disease

    A. Tröster, A. Novak, S. Russell, K. Hanson (Phoenix, USA)

    Objective: To compare cognitive, psychiatric and quality of life (QoL) outcomes after awake and asleep bilateral pallidal (GPi) deep brain stimulation (DBS). Background: Prior studies…
  • 2023 International Congress

    SAFE-DBS – A monocentric, randomised, blind evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation

    E. Gülke, M. Höfs, H. Pinnschmidt, A. Gulberti, C. Moll, U. Hidding, C. Buhmann, M. Heise, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)

    Objective: This monocentric, randomised, blind study is designed to evaluate the effect of safinamide on motor and neuropsychiatric symptoms in the 3 month perioperative period…
  • 2023 International Congress

    Real-life monitoring of Parkinson’s disease tremor: does the non-tremor subtype really exist?

    R. Terranova, L. Evers, D. Soriano, Y. Raykov, M. Little, H. Cagnan, B. Bloem, R. Helmich (Catania, Italy)

    Objective: To quantify daily-life tremor in Parkinson’s disease (PD) using a smartwatch containing a three-axis accelerometer and gyroscope. Background: Objective and continuous evaluation of PD…
  • 2023 International Congress

    Altered brain energetics in Parkinson’s Disease: a multimodal neuroimaging study

    C. Bevington, J-C. Cheng, R. Jayde-Williams, B. Pike, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To investigate patterns of altered brain energetics in Parkinson’s disease (PD). Background: Alterations in mitochondrial function, related to brain energetics, may play an important…
  • 2023 International Congress

    Preliminary Report on the Safety and Tolerability of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for Parkinson’s disease: Phase IIa double-blind, randomized controlled trial

    J. Suescun, T. Ellmore, C. Adams, V. Thyne, E. Tharp, S. Chandra, C. Green, R. Shastri, J. Saltarrelli, M. Schiess (Houston, USA)

    Objective: To select the safest and most effective number of repeat doses of allogeneic mesenchymal stem cells (MSC) purified from bone marrow-derived from a healthy…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley